Wednesday - July 08, 2026

Category Archives: Science

Metastatic Castration-Resistant Prostate Cancer Pipeline Gains Momentum: 75+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s “Metastatic Castration-Resistant Prostate Cancer Pipeline Insights 2026” report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Metastatic Castration-Resistant Prostate Cancer pipeline landscape. It covers the Metastatic Castration-Resistant Prostate Cancer pipeline drug profiles, including clinical and … Continue reading →

Peanut Allergy Pipeline Report Gains Momentum: 12+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “Peanut Allergy Pipeline Insight, 2026” report provides comprehensive insights about 12+ companies and 15+ pipeline drugs in Peanut Allergy pipeline landscape. It covers the Peanut Allergy pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Metastatic Prostate Cancer Pipeline Gains Momentum: 80+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “Metastatic Prostate Cancer Pipeline Insights 2026” report provides comprehensive insights about 80+ companies and 85+ pipeline drugs in Metastatic Prostate Cancer pipeline landscape. It covers the Metastatic Prostate Cancer pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading →

Leptomeningeal Metastases Market is Projected to Witness Significant Growth by 2036 Owing to the Launch of Novel CNS-Targeted Therapies and Precision Oncology Treatments | DelveInsight

The Leptomeningeal Metastases Market is growing due to the rising incidence of advanced cancers with CNS involvement, improved survival among cancer patients, and better diagnosis through contrast-enhanced MRI, CSF cytology, and molecular testing. Advances in targeted therapies, immunotherapies, and pipeline … Continue reading →

Chronic Pain Market is Projected to Witness Significant Growth by 2036 Owing to the Launch of Novel Non-Opioid Pain Therapies and Innovative Chronic Pain Drugs | DelveInsight

The Chronic Pain Market is growing due to the rising prevalence of chronic pain conditions, an aging population, increasing musculoskeletal and neuropathic disorders, and demand for non-opioid therapies. Advances in pain management and emerging treatments such as ZILOSUL, HP-5000, AMZ001, … Continue reading →

Staphylococcus aureus Bacteremia (SAB) Market is Projected to Boom by 2036 Owing to the Launch of Novel Therapies | DelveInsight

The market dynamics for Staphylococcus aureus Bacteremia (SAB) is witnessing steady growth driven by the increasing incidence of bloodstream infections, rising prevalence of methicillin-resistant Staphylococcus aureus (MRSA), growing adoption of rapid diagnostic technologies, and advancements in targeted anti-infective therapies. Additionally, … Continue reading →

Renal Cancer Pipeline Appears Robust With 75+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s, “Renal Cancer Pipeline Insight 2026” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Renal Cancer pipeline landscape. It covers the Renal Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Human Papillomavirus-positive Oropharyngeal Cancer Pipeline Appears Robust With 5+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s, “Human Papillomavirus-positive Oropharyngeal Cancer Pipeline Insight 2026” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Human Papillomavirus-positive Oropharyngeal Cancer pipeline landscape. It covers the Human Papillomavirus-positive Oropharyngeal Cancer pipeline drug profiles, including clinical and nonclinical … Continue reading →

Perennial Allergic Rhinitis Market is Projected to Boom by 2036 Owing to the Launch of Novel Therapies | DelveInsight

The market dynamics for Perennial Allergic Rhinitis is witnessing steady growth driven by increasing disease awareness, rising exposure to indoor allergens, improving diagnosis rates, and the growing adoption of immunotherapy. Additionally, the launch of emerging therapies such as LY3650150 (lebrikizumab, … Continue reading →

X-Linked Retinitis Pigmentosa (XLRP) Market is Projected to Boom by 2036 Owing to the Launch of Novel Gene Therapies | DelveInsight

The market dynamics for X-Linked Retinitis Pigmentosa (XLRP) is witnessing steady growth driven by increasing awareness of inherited retinal disorders, advances in genetic diagnosis, expanding research in retinal gene therapy, and growing investment in precision medicine. Additionally, the launch of … Continue reading →